TipRanks
Go Ultimate55% OFF

Arch Biopartners (ARCH) Ownership - Who Owns Arch Biopartners?

Arch Biopartners (ARCH) Ownership Overview

  • 16.48% Insiders
  • 83.52% Public Companies and Individual Investors

The ownership structure of Arch Biopartners (TSE:ARCH) stock is a mix of institutional, retail, and individual investors. , 16.48% is owned by Insiders, and 83.52% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Oct 21, 2026Richard Gabriel MuruveC$6,620
Oct 05, 2026Richard Gabriel MuruveC$90,812
Sep 15, 2026Richard Gabriel MuruveC$13,532
Sep 13, 2026Richard Gabriel MuruveC$5,078

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

TSE:ARCH top shareholders
Holder# of SharesType% HoldingValue
Richard Gabriel Muruve9,243,650Insider13.61%5,213,419
Richard Lawrence Rossman1,952,280Insider2.87%1,101,086

FAQ

What percentage of Arch Biopartners (TSE:ARCH) stock is held by retail investors?
According to the latest TipRanks data, approximately 83.52% of Arch Biopartners (TSE:ARCH) stock is held by public companies and individual investors.
Who owns the most shares of Arch Biopartners (TSE:ARCH)?
Richard Gabriel Muruve owns the most shares of Arch Biopartners (TSE:ARCH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.